tiprankstipranks
AN2 Therapeutics, Inc. (ANTX)
NASDAQ:ANTX
US Market
ANTX
AN2 Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see ANTX full AI Analyst Report?

AN2 Therapeutics, Inc. (ANTX) Income Statement

106 Followers

AN2 Therapeutics, Inc. Income Statement

Last quarter (Q4 2025), AN2 Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, AN2 Therapeutics, Inc.'s net income was $-8.71M. See AN2 Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ -77.00K$ 0.00
Operating Expenses
$ 38.11M$ 54.55M$ 69.64M$ 42.19M$ 21.57M
Depreciation and Amortization
$ 0.00$ 54.55M$ 69.64M$ 77.00K$ 0.00
EBITDA
$ -38.11M$ 3.23M$ 4.90M$ -40.88M$ -21.57M
Operating Income
$ -38.11M$ -54.55M$ -69.64M$ -42.26M$ -21.57M
Other Income/Expenses
$ 2.94M$ 3.23M$ 4.90M$ 1.31M$ 31.00K
Pretax Income
$ -35.17M$ -51.32M$ -64.73M$ -40.96M$ -21.54M
Net Income
$ -35.17M$ -51.32M$ -64.73M$ -40.96M$ -21.54M
Per Share Metrics
Basic EPS
$ -1.16$ -1.72$ -2.74$ -2.79$ -1.50
Diluted EPS
$ -1.16$ -1.72$ -2.74$ -2.79$ -1.50
Weighted Average Shares Outstanding
 30.22M 29.83M 23.60M 15.34M 18.74M
Weighted Average Shares Outstanding (Diluted)
 30.22M 29.83M 23.60M 15.34M 18.74M
Currency in USD

AN2 Therapeutics, Inc. Earnings and Revenue History